Naba Alsaha Medical Services Company
SAR 22.00+SAR 0.02 (+0.09%)
Naba Alsaha Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 28.92% below the high.
SAU · 9592.SR · SAR
Stock price, dividends
Quote as of Oct 28, 2026, 11:57 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Almujtama Alraida Medical Co.’s quoted price sits in the lower half of its reported 52-week range, 33.37% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Almujtama Alraida Medical Co. delivers a variety of healthcare services. The company specializes in the retail of pharmaceuticals, medical products, cosmetics, and toiletries, offering these items through its dedicated network of stores, which encompass outlets for medical devices, beauty products, and pharmaceutical goods. Furthermore, its operational scope includes pharmaceutical laboratories. Established in 2001 by Abdulaziz Omar Yousef Khoja, the entity is headquartered in Jeddah, Saudi Arabia.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 12:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 22.00+SAR 0.02 (+0.09%)
Naba Alsaha Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 28.92% below the high.
SAR 17.50SAR 0.00 (0.0%)
Arabian International Healthcare Holding Company’s quoted price sits in the lower half of its reported 52-week range, 36.41% below the high.
SAR 80.60+SAR 0.10 (+0.12%)
Professional Medical Expertise Co.’s quoted price sits in the lower half of its reported 52-week range, 24.67% below the high.
SAR 3.80SAR 0.00 (0.0%)
Al-Modawat Specialized Medical Co.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
SAR 29.80-SAR 2.20 (-6.88%)
Qomel Company Limited’s quoted price sits in the lower half of its reported 52-week range, 53.44% below the high.
SAR 87.40+SAR 0.40 (+0.46%)
Miral Dental Clinics Co.’s quoted price sits in the lower half of its reported 52-week range, 24.2% below the high.
SAR 6.16-SAR 0.04 (-0.65%)
Basma Adeem Medical Co.’s quoted price sits in the upper half of its reported 52-week range, 12.0% below the high.
SAR 1.80+SAR 0.23 (+14.65%)
Lana Medical Co.’s quoted price sits in the lower half of its reported 52-week range, 48.57% below the high.